Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas–Implications for tumor biology and potential clinical utility
Michael C. Frühwald(University Hospital Augsburg), Christoph Plass(German Cancer Research Center), M. Sue O’Dorisio(The Ohio State University), Xīn Gào(Qingdao University), Stephan M. Tanner(Cancer Genetics (United States)), Fred A. Wright(North Carolina State University), Zunyan Dai(The Ohio State University), Douglas A. Balster(The Ohio State University)
Cited by 93
Related Papers
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
|Science|2015|5.7k
The human transcriptome across tissues and individuals
|Science|2015|1.4k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Correction: Corrigendum: Synchronized age-related gene expression changes across multiple tissues in human and the link to complex diseases
|Scientific Reports|2016|722
Heritability and genomics of gene expression in peripheral blood
|Nature Genetics|2014|424